Tattooist-Associated Tattoo Complications: “Overworked Tattoo,” “Pigment Overload” and Infections Producing Early and Late Adverse Events

Dermatology ◽  
2019 ◽  
Vol 236 (3) ◽  
pp. 208-215 ◽  
Author(s):  
Katrina Hutton Carlsen ◽  
Mitra Sepehri ◽  
Jørgen Serup

Background: Tattooist-related technical failures of tattooing were hitherto unstudied and related to clinical complications. Tattooing requires talent, training and experience. Amateurism is a challenge in popular tattoo industry with no formal education and certification of the tattooists. Objective: To study technical tattoo failures causing disease in a consecutive hospital material of tattoo complications. Material: 574 patients with 702 tattoo complications referred to the “Tattoo Clinic” (a subspecialised dermatological clinic) were enrolled. Patients were examined clinically and classified with respect to the cause of complication. Results: 147 (21%) tattooist and tattoo studio-related complications were recorded, i.e. excessive pigment installed in the dermis with “pigment overload” in 64 (9%), tattoo “needle trauma” with “overworked tattoos” in 43 (6%), contaminated ink causing infection in 20 (3%), and other sources of infections related to tattooing in 20 (3%). Pain and discomfort were particularly common as well as long-term complications including scarring induced by “needle trauma.” “Pigment overload” with black pigment carried a special risk of granulomatous inflammation and sarcoid granuloma and was observed in 12/35 (34%) of punch biopsies taken from tattoos with “pigment overload.” Keratoacanthoma associated with trauma was observed in 1 case. 82% of complications were related to professional tattooists working in a tattoo studio and 18% to amateurs. Conclusion: Technical failures of tattooing are associated with medical tattoo complications. “Needle trauma” with major skin damage, e.g. “overworked tattoo,” and installation of excessive pigment, e.g. “pigment overload,” and (re)use of contaminated tattoo ink bottles are identified failures calling for preventive intervention.

2011 ◽  
Author(s):  
Nicole E. Mahrer ◽  
Colleen M. Carr ◽  
Sharlene A. Wolchik ◽  
Irwin N. Sandler ◽  
Jenn-Yun Tein

MedAlliance ◽  
2020 ◽  
Vol 8 (1) ◽  
pp. 54-60

2 clinical observations of generalized forms of mycobacteriosis in HIV (+) patients complicated by secondary spinal lesion are described. Anamnestic data on the presence of mycobacteriosis of the lungs allowed to suspect a secondary lesion of the spine. Verification of the diagnosis is possible only with bacteriological confirmation, since the histological picture is nonspecific and resembles tuberculous granulomatous inflammation. Treatment of spondylitis caused by non-tuberculous mycobacteria is complex and includes both surgical rehabilitation of the focus and long-term (at least 1 year) antibiotic therapy.


2021 ◽  
Vol 82 (01) ◽  
pp. 100-106 ◽  
Author(s):  
Jane S. Kim ◽  
Jason Liss

AbstractLacrimal gland lesions account for approximately 9 to 10% of all biopsied orbital masses. Potential causes include nongranulomatous and granulomatous inflammation, autoimmune disease, lymphoproliferative disorders, benign epithelial proliferation, malignant neoplasia, and metastatic disease. Inflammatory lesions and lymphoproliferative disorders are the most common and may be unilateral or bilateral; they may also be localized to the orbit or associated with systemic disease. Both benign and malignant epithelial lacrimal gland masses tend to be unilateral and involve the orbital lobe, but a more rapid onset of symptoms and periorbital pain strongly suggest malignant disease. On orbital imaging, both inflammatory and lymphoproliferative lesions conform to the globe and surrounding structures, without changes in adjacent bone, whereas epithelial lacrimal gland masses often show scalloping of the lacrimal gland fossa. Malignant epithelial lacrimal gland tumors can also have radiographic evidence of bony invasion and destruction. Masses of the lacrimal gland may be due to a broad range of pathologies, and a good working knowledge of common clinical characteristics and radiographic imaging findings is essential for diagnosis and treatment. All patients with inflammatory, lymphoproliferative, and epithelial neoplastic lesions involving the lacrimal gland require long-term surveillance for disease recurrence and progression.


2018 ◽  
Vol 60 (4) ◽  
pp. 283-300 ◽  
Author(s):  
Sharlene Wolchik ◽  
Caroline Christopher ◽  
Jenn-Yun Tein ◽  
C. Aubrey Rhodes ◽  
Irwin N. Sandler

Author(s):  
Akhmadu Muradi ◽  
Chyntia Olivia Maurine Jasirwan ◽  
Raden Suhartono ◽  
Patrianef Darwis ◽  
Dedy Pratama ◽  
...  

Non-cirrhotic portal hypertension (NCPH) is a heterogeneous group of liver disorders leading to portal hypertension. There are multiple approaches to managing portal hypertension' clinical complications to treat/prevent spontaneous hemorrhage by mitigating thrombocytopenia. Portal hypertension complications have been traditionally managed with serial endoscopic variceal ligation (EVL) or with invasive open surgical procedures such as orthotopic liver transplantation (OLT) or portosystemic shunting, splenectomy.6–9 There are several risks associated with splenectomies, such as hemorrhagic complications or intraoperative blood loss.5,6,14 Partial Spleen Embolization (PSE) ‎may overcome the limitations of splenectomy and provide patients with an alternative treatment. An eighteen-year-old male has a splenomegaly history since he was 12 years old and has recurring hematemesis and melena. After performing abdominal computed tomography, laboratory studies, and several endoscopies, the results indicated secondary hypersplenism due to non-cirrhotic portal hypertension. The patient had 13 endoscopies and 2 EVL in 5 years. Despite adequate treatment, the patients developed recurrent variceal bleeding and no improvement in blood function. The patient underwent PSE at Integrated Cardiovascular Center in Dr. Cipto Mangunkusumo, General Hospital, Jakarta, Indonesia. It was performed through the femoral access with a PVA (polyvinyl alcohol) embolus. The procedure went successful, and there was no major complication with the patient. Twenty days after the patient had an abdominal CT scan, it showed no abscess, and the spleen volume was reduced by 20%. Long-term results over a  year after the procedure are presented. PSE is a safe, effective, semi-invasive alternative to splenectomy in non-cirrhotic portal hypertension because it preserves functional spleen mass and avoids postprocedure accelerated liver disease or encephalopathy.


2018 ◽  
Vol 11 (1) ◽  
pp. 1-27
Author(s):  
Phillip M. Carter ◽  
Tonya E. Wolford

Abstract This study investigates variation in the grammatical system of Spanish in the speech of three generations of Mexican Americans living in a community in South Texas, United States, characterized by high levels of bilingualism and long-term, sustained contact between languages. Two variables are studied using quantitative methods: (1) the extension of the copula verb estar into domains traditionally confined to ser and (2) the expansion of progressive forms at the expense of the simple present. The data reported here suggest changes-in-progress that appear to be accelerated by the linguistic and sociocultural conditions of the community including, especially, lack of access to formal education in Spanish. The sociolinguistic patterning for these variables is compared to patterning for the same variables reported in the literature in both monolingual communities in Spain and Latin America and bilingual communities in the United States.


2019 ◽  
Vol 2019 ◽  
pp. 1-6 ◽  
Author(s):  
Nils Kristian Prenzler ◽  
Eugen Kludt ◽  
Thomas Giere ◽  
Rolf Salcher ◽  
Thomas Lenarz ◽  
...  

Objectives/Hypothesis. Comparing long term stability of the Middle Ear Transducers (MET) of the 1st generation T1 (Otologics LLC) with the current generation T2 (Cochlear Ltd.) in all our clinical cases with standard incus coupling. Study Design. Retrospective chart review. Methods. 52 ears implanted with a MET device between 2008 and 2016 were analyzed retrospectively. All patients suffered from sensorineural hearing loss and the actuator was coupled to the body of the incus (standard coupling). 23 ears were implanted with the transducer T1 (Otologics LLC) between 2008 and 2011 and 29 ears were implanted with the current transducer T2 since 2011 (Otologics LLC/Cochlear Ltd.). Latest available in situ and bone conduction (BC) thresholds were exploited for a follow-up period of up to 7 years after first fitting. Long term stability of coupling and actuator performance was evaluated by tracking differences between in situ and BC thresholds. Results. In the T1 group, 9 out of 23 implants were still used by the patients at their last follow-up visit (average observation time 3.7 yrs.; min 1.0 yrs., max 7.4 yrs.). In 9 patients a technical failure identified by a decrease of in situ threshold of more than 15 dB compared to BC thresholds [Δ (in situ – BC)] lead to non-usage of the implant and 7 explantations. Five other explantations occurred due to medical reasons such as BC threshold decrease, infection, or insufficient speech intelligibility with the device. In the T2 group, 23 out of 29 implants were still used at the most current follow-up visit (average observation time 3.3 yrs.; min 1.0 yrs., max 4.8 yrs.). No technical failures were observed up to more than 4 years after implantation. Five T2 patients discontinued using the device due to insufficient benefit; two of these patients were explanted. One patient had to be explanted before the activation of the device due to disorders of wound healing. Nevertheless, a small but significant decrease of hearing loss corrected coupling efficiency [Δ (in situ – BC)] was seen in the T2 group. Conclusions. In contrast to the T1 transducers of the earlier generation of MET systems where technical failures occurred frequently, no technical failures were detected after 29 implantations with the current T2 transducers. However, a small but significant decline of transmission efficiency was observable even in the T2 implanted group.


2008 ◽  
Vol 37 (2) ◽  
pp. 386-396 ◽  
Author(s):  
Laurie Miller Brotman ◽  
Kathleen Kiely Gouley ◽  
Keng-Yen Huang ◽  
Amanda Rosenfelt ◽  
Colleen O'Neal ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document